SLC7A11 and ovarian cancer: The overexpression of SLC7A11 increased the paclitaxel sensitivity of paclitaxel-resistant ovarian cancer cells HeyA8-R, induced cell apoptosis, and arrested the cell cycle (Figures 4–7A).